Turning Dexmedetomidine Into a Powerful Anesthetic That Can be Rapidly and Completely Reversed
Status:
Not yet recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
In this study, the investigators will explore Atipamezole & caffeine's ability to facilitate
the emergence from anesthesia. Each subject will visit UChicago 4 times. The first time for
informed consent. The second time for a complete physical exam to ensure that the subjects
are healthy. Then there are 2 sedation sessions. Subjects get an honorarium for each sedation
session.